Citation Impact

Citing Papers

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding
2008
Latrophilins Function as Heterophilic Cell-adhesion Molecules by Binding to Teneurins
2013 StandoutNobel
Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
2012
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus
2012
Early steps of the hepatitis C virus life cycle
2008
Cell Culture Systems for Hepatitis C Virus
2013
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Development of novel therapies for hepatitis C
2010
IFITm1 Is a Tight Junction Protein That Inhibits Hepatitis C Virus Entry
2012
Elucidating the principles of the molecular organization of heteropolymeric tight junction strands
2011
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Latrophilin Signaling Links Anterior-Posterior Tissue Polarity and Oriented Cell Divisions in the C. elegans Embryo
2009
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
Hepatitis C virus—host interactions, replication, and viral assembly
2012
Characterization of the Cross-Neutralizing Antibody Response Against Hepatitis C Virus in the Liver Transplantation Setting
2011
Role of lipid metabolism in hepatitis C virus assembly and entry
2009
α-Latrotoxin and Its Receptors
2007
Early infection events highlight the limited transmissibility of hepatitis C virus in vitro
2013
Receptors and routes of dengue virus entry into the host cells
2015
Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion
2011
Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
2012
Functional Classification and Experimental Dissection of Long Noncoding RNAs
2018 Standout
TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins
2016 StandoutNobel
Advances in experimental systems to study hepatitis C virus in vitro and in vivo
2015
Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study
2013
Mechanism of Clostridium perfringens Enterotoxin Interaction with Claudin-3/-4 Protein Suggests Structural Modifications of the Toxin to Target Specific Claudins
2011
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
2010
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
2009
The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases
2017
Metazoan MicroRNAs
2018 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Adaptive Immunity to the Hepatitis C Virus
2010
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
2019 StandoutNobel
The MicroRNA miR-1 Regulates a MEF-2-Dependent Retrograde Signal at Neuromuscular Junctions
2008 StandoutNobel
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies
2013
High Affinity Neurexin Binding to Cell Adhesion G-protein-coupled Receptor CIRL1/Latrophilin-1 Produces an Intercellular Adhesion Complex
2012 StandoutNobel
Roles of Puf proteins in mRNA degradation and translation
2010
Cell-Type-Specific Profiling of Gene Expression and Chromatin Binding without Cell Isolation: Assaying RNA Pol II Occupancy in Neural Stem Cells
2013
Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
2010
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Neuroligins and neurexins link synaptic function to cognitive disease
2008 StandoutNatureNobel
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
Mechanisms of voltage-gated ion channel regulation: from gene expression to localization
2008
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Hepatitis C Virus Entry
2007 StandoutNobel
The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination
2012
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics
2010
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
2010
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels
2009
Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
2013
The Transcription Factor Mef2 Links the Drosophila Core Clock to Fas2, Neuronal Morphology, and Circadian Behavior
2013 StandoutNobel
Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation
2011
Claudin-1 involved in neonatal ichthyosis sclerosing cholangitis syndrome regulates hepatic paracellular permeability
2011
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
PUF proteins: repression, activation and mRNA localization
2010
Nociceptors: the sensors of the pain pathway
2010 StandoutNobel
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Entry and replication of recombinant hepatitis C viruses in cell culture
2012
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Occludin Protein Family: Oxidative Stress and Reducing Conditions
2011
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells
2012
Nanoscale distribution of mitochondrial import receptor Tom20 is adjusted to cellular conditions and exhibits an inner-cellular gradient
2011 StandoutNobel
Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection
2008
Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts
2009
Hepatitis C Virus Entry
2013
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
2011 StandoutNobel
A bacterial Argonaute with noncanonical guide RNA specificity
2016 StandoutNobel
Structural characterization of CD81–Claudin-1 hepatitis C virus receptor complexes
2011
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
2010
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
2010
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells
2013
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles
2011
MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR
2011
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Hepatitis C Virus Induces CD81 and Claudin-1 Endocytosis
2012
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Virus‐neutralizing antibodies to hepatitis C virus
2013
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
2018
Development of NS3/4A Protease-Based Reporter Assay Suitable for Efficiently Assessing Hepatitis C Virus Infection
2009
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
2008
Spider-Venom Peptides: Structure, Pharmacology, and Potential for Control of Insect Pests
2012
Hepatitis C Virus Induces Epidermal Growth Factor Receptor Activation via CD81 Binding for Viral Internalization and Entry
2012
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Immunopurification of Ago1 miRNPs selects for a distinct class of microRNA targets
2009 StandoutNobel
Crystal structures of claudins: insights into their intermolecular interactions
2017

Works of Christopher Mee being referenced

The homeobox transcription factor Even-skipped regulates acquisition of electrical properties in Drosophila neurons
2006
Claudin Association with CD81 Defines Hepatitis C Virus Entry
2010
Fusion proteins containing insect-specific toxins as pest control agents: snowdrop lectin delivers fused insecticidal spider venom toxin to insect haemolymph following oral ingestion
2003
Contributions from Caenorhabditis elegans functional genetics to antiparasitic drug target identification and validation: Nicotinic acetylcholine receptors, a case study
2006
Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
2010
Regulation of Neuronal Excitability through Pumilio-Dependent Control of a Sodium Channel Gene
2004
Hepatitis C Virus Infection Reduces Hepatocellular Polarity in a Vascular Endothelial Growth Factor–Dependent Manner
2009
Inhibition of hepatitis C virus infection by anti‐claudin‐1 antibodies is mediated by neutralization of E2–CD81–Claudin‐1 associations†
2009
Latrophilin is required for toxicity of black widow spider venom in Caenorhabditis elegans
2004
Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity
2008
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
2009
Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization
2009
CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry
2008
Effect of Cell Polarization on Hepatitis C Virus Entry
2007
Rankless by CCL
2026